Currently, semaglutide is the only orally administered GLP-1 RA approved by the US Food and Drug Administration for the treatment of T2D
When glycemic control improves too quickly, patients with existing diabetic retinopathy may experience paradoxical worsening of their retinal disease
Beyond these metabolic benefits, large-scale cardiovascular outcome trials (CVOTs) have consistently demonstrated that several GLP-1 RAs significantly reduce major adverse cardiovascular events, suggesting cardioprotective effects that extend beyond glycemic and weight control (16)
Ahmad I, El-Boghdadly K, Iliff H, Dua G, Higgs A, Huntington M, et al
The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science , 19(8), 969988
If youre considering Ozempic for weight loss, our medical team is here to guide you in creating a personalized treatment plan tailored to your needs